Domvanalimab + Zimberelimab

About Gilead

Gilead Sciences is a fully integrated biopharmaceutical giant with a mission to create a healthier world by advancing transformative therapies for serious diseases. It achieved historic success by pioneering curative treatments for hepatitis C and life-sustaining regimens for HIV, establishing a dominant virology franchise. The company's current strategy is to expand its leadership into oncology and inflammation through internal R&D and strategic acquisitions, while maintaining its commitment to health equity and global access.

Therapeutic Areas